https://www.live-feeds.com/feed/cancer-vaccines-are-the-n-i-h-s-next-big-betContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/cancer-vaccines-are-the-n-i-h-s-next-big-bethttps://www.live-feeds.com/feed/cancer-vaccines-are-the-n-i-h-s-next-big-bet#u126089Fri, 16 Oct 2026 13:31:43 +0000The National Institutes of Health plans to expedite cancer vaccines through a new national initiative, sparking significant market momentum across the biotechnology sector. Vaccine developer stocks experienced sharp gains following reports of the federal push, with Moderna shares climbing to a four-year high and other developers such as BioNTech and Novavax also rallying. The broader oncology market has drawn intense attention from retail investors as researchers pursue innovative mRNA and RNA technologies to target aggressive cancers.Why it mattersFederal backing for accelerated vaccine devel